1. IGF-1R and ErbB3/HER3 contribute to enhanced proliferation and carcinogenesis in trastuzumab-resistant ovarian cancer model
   Yanhan Jia et al, 2013, Biochemical and Biophysical Research Communications CrossRef
2. Bispecific radioimmunoconjugates exploit receptor heterogeneity for positron emission tomography of tumors expressing HER2 and/or EGFR
   Luke Yongkyu Kwon et al, 2024, iScience CrossRef
3. Fluorescence Lifetime Imaging for Quantification of Targeted Drug Delivery in Varying Tumor Microenvironments
   Amit Verma et al, 2024, Advanced Science CrossRef
4. Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases
   Santosh Kumar Behera et al, 2015, Glycoconjugate Journal CrossRef
5. Efficacy of HER2-Targeted Intraperitoneal225Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis
   Sebastian K. Chung et al, 2023, Journal of Nuclear Medicine CrossRef
6. Quantifying Cellular Internalization with a Fluorescent Click Sensor
   Laura I. Selby et al, 2018, ACS Sensors CrossRef
7. A Novel Method for Real-Time Quantification of Radioligand Binding to Living Tumor Cells In Vitro
   Tom Bäck et al, 2024, Cancer Biotherapy and Radiopharmaceuticals CrossRef
8. Design and characterization of a time-domain optical tomography platform for mesoscopic lifetime imaging
   Shan Gao et al, 2022, Biomedical Optics Express CrossRef